Lucas Vitale Sells 4,287 Shares of Orthofix Medical Inc. (NASDAQ:OFIX) Stock

Orthofix Medical Inc. (NASDAQ:OFIX) insider Lucas Vitale sold 4,287 shares of the business’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $16.60, for a total transaction of $71,164.20. Following the completion of the transaction, the insider now owns 135,317 shares in the company, valued at $2,246,262.20. This represents a 3.07 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Orthofix Medical Stock Down 1.6 %

Shares of Orthofix Medical stock opened at $16.63 on Friday. The company has a quick ratio of 1.11, a current ratio of 2.39 and a debt-to-equity ratio of 0.25. The firm has a market cap of $648.94 million, a P/E ratio of -5.31 and a beta of 1.06. Orthofix Medical Inc. has a fifty-two week low of $12.08 and a fifty-two week high of $20.73. The business has a 50-day moving average price of $17.77 and a 200 day moving average price of $17.36.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on OFIX. Roth Mkm reaffirmed a “buy” rating and set a $22.00 target price on shares of Orthofix Medical in a research report on Wednesday, February 26th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $24.00 target price on shares of Orthofix Medical in a research report on Wednesday, February 26th. Finally, StockNews.com raised shares of Orthofix Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, February 25th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $23.33.

Institutional Investors Weigh In On Orthofix Medical

A number of institutional investors have recently made changes to their positions in the company. Lazard Asset Management LLC bought a new stake in Orthofix Medical during the fourth quarter valued at $45,000. R Squared Ltd bought a new stake in shares of Orthofix Medical during the 4th quarter valued at about $50,000. KLP Kapitalforvaltning AS bought a new stake in shares of Orthofix Medical during the 4th quarter valued at about $112,000. Tower Research Capital LLC TRC grew its position in shares of Orthofix Medical by 120.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 8,458 shares of the medical device company’s stock valued at $148,000 after buying an additional 4,627 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Orthofix Medical by 5.9% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,994 shares of the medical device company’s stock valued at $156,000 after buying an additional 559 shares during the last quarter. 89.76% of the stock is currently owned by institutional investors.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.